SAMHD1 compound heterozygous rare variants associated with moyamoya and mitral valve disease in the absence of other features of Aicardi–Goutières syndrome
American Journal of Medical Genetics Part A · 2024
DOI: 10.1002/ajmg.a.63486 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, 2024. Verfasst von Aamuktha R Karla und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas, USA. Hauptthemen laut MEDLINE: Moyamoya Disease, Nervous System Malformations, Autoimmune Diseases of the Nervous System, Brain Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHGRI NIH HHS, NHLBI NIH HHS, American Heart Association.
Abstract (Originalsprache)
Aicardi–Goutières syndrome (AGS) is an autosomal recessive inflammatory syndrome that manifests as an early‐onset encephalopathy with both neurologic and extraneurologic clinical findings. AGS has been associated with pathogenic variants in nine genes: TREX1 , RNASEH2B , RNASEH2C , RNASEH2A , SAMHD1 , ADAR , IFIH1 , LSM11 , and RNU7 ‐ 1 . Diagnosis is established by clinical findings (encephalopathy and acquired microcephaly, intellectual and physical impairments, dystonia, hepatosplenomegaly, sterile pyrexia, and/or chilblains), characteristic abnormalities on cranial CT (calcification of the basal ganglia and white matter) and MRI (leukodystrophic changes), or the identification of pathogenic/likely pathogenic variants in the known genes. One of the genes associated with AGS, SAMHD1 , has also been associated with a spectrum of cerebrovascular diseases, including moyamoya disease (MMD). In this report, we describe a 31‐year‐old male referred to genetics for MMD since childhood who lacked the hallmark features of AGS patients but was found to have compound heterozygous SAMHD1 variants. He later developed mitral valve insufficiency due to recurrent chordal rupture and ultimately underwent a heart transplant at 37 years of age. Thus, these data suggest that SAMHD1 pathogenic variants can cause MMD without typical AGS symptoms and support that SAMHD1 should be assessed in MMD patients even in the absence of AGS features.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas, USA.
- Department of Neurology, Ghent University Hospital, Ghent, Belgium.
- Department of Internal Medicine and Pediatrics, Center for Primary Immunodeficiency, Jeffrey Modell Diagnosis and Research Center, Ghent University Hospital, Ghent, Belgium.
- Department of Cardiology, Ghent University Hospital, Ghent, Belgium.
- Department of Radiology, Ghent University Hospital, Ghent, Belgium.
- Division of Child Neurology, Department of Pediatrics, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas, USA.
ORCID-Profile: Aamuktha R Karla, Bert Callewaert
Förderung
- NHGRI NIH HHS
- NHLBI NIH HHS
- American Heart Association
- Texas Heart Institute
- Henrietta B. and Frederick H. Bugher Foundation
- NIH HHS
- National Heart, Lung, and Blood Institute
- National Human Genome Research Institute
Zitieren
APA
Karla, A. R., Pinard, A., Boerio, M. L., Hemelsoet, D., Tavernier, S. J., De Pauw, M., Vereecke, E., Fraser, S., Bamshad, M. J., Guo, D., Callewaert, B., & Milewicz, D. M. (2024). SAMHD1 compound heterozygous rare variants associated with moyamoya and mitral valve disease in the absence of other features of Aicardi–Goutières syndrome. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.63486
Vancouver
Karla AR, Pinard A, Boerio ML, Hemelsoet D, Tavernier SJ, De Pauw M, et al. SAMHD1 compound heterozygous rare variants associated with moyamoya and mitral valve disease in the absence of other features of Aicardi–Goutières syndrome. American Journal of Medical Genetics Part A. 2024. doi:10.1002/ajmg.a.63486
BibTeX
@article{Karla2024,
author = {Karla, Aamuktha R and Pinard, Amélie and Boerio, Maura L and Hemelsoet, Dimitri and Tavernier, Simon J and De Pauw, Michel and Vereecke, Elke and Fraser, Stuart and Bamshad, Michael J and Guo, Dongchuan and Callewaert, Bert and Milewicz, Dianna M},
title = {SAMHD1 compound heterozygous rare variants associated with moyamoya and mitral valve disease in the absence of other features of Aicardi–Goutières syndrome},
journal = {American Journal of Medical Genetics Part A},
year = {2024},
doi = {10.1002/ajmg.a.63486}
}
EUVIMED